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Fig. 1. Thick liver section immune-stained against GFAP and CD163 for
detecting hepatic stellate cells (HSC) and Kupffer cells (KC), respectively. The
liver of 5 male Wistar rats (2 months) was collected and 5 thick parafﬁn sections
(35 lm), per animal, were used to quantify the juxtaposition of HSC-KC. After
antigen retrieval (4 + 4 + 4 minutes in the microwave), a double immunohisto-
chemistry was performed against GFAP [rabbit polyclonal (Dako) 1:1500, 4 days]
and CD163 [mouse monoclonal (Serotec) 1:100, another 4 days]. Cells were
systematic uniform random sampled and counted in optical disectors (minimum
of 200 cells per animal, sorting apart and juxtapositioned cells). HSC (diam-
inobenzidine brown color, open arrow) and KC (aminoethylcarbazole red color,
block arrow) were counted using a counting frame of 1673 lm2 (here depicted for
illustrative purposes). Cells were counted if their nucleus was in focus and inside
the inclusion (green) lines, not touching the exclusion (red) ones; bar = 6 lm.
(This ﬁgure appears in colour on the web.)To the Editor:
In a recent issue of this journal, Stewart et al. [1] presented a
major breakthrough in liver research models. The authors used
transgenic mice expressing herpes simplex virus thymidine
kinase (TK) under the glial ﬁbrillary acidic protein (GFAP) pro-
moter. Proliferation of hepatic stellate cells (HSC) was ﬁrst
induced by CCl4 and then mice were treated with ganciclovir,
which was metabolized by TK into toxic nucleotide analogues,
ultimately leading to HSC death (70% depletion). Afterwards,
mice were subjected to ischemia/reperfusion and to endotoxin
treatments. The role of HSC in these acute injuries was studied
– so far it has not yet been evaluated in detail. Notably, the
magnitude of liver disease was lowered in HSC depleted mice,
as expressed by reduced serum transaminases, neutrophil
inﬁltration, tumor necrosis factor-a (TNF-a), and endothelin-A
receptor in both conditions. In contrast, levels of interleukin-6
and endothelin-1 increased signiﬁcantly, but only in the
ischemia/reperfusion and endotoxin treatment, respectively [1].
Endothelin-B receptor behaved differently, being unchanged
(ischemia/reperfusion) or as much elevated in depleted and
non-depleted mice after endotoxin treatment. The authors con-
cluded that HSC should be major producers of TNF-a, neutrophil
chemoattractant factors, and endothelin-A receptor, thus having
a critical role in ischemia/reperfusion and in endotoxin induced
liver injuries.
Throughout years, a leading role has been ascribed to Kupffer
cells (KC) in acute liver conditions [2]. They may have been
dethroned, but it is noteworthy that a recent review published
in this journal, devoted to KC heterogeneity, emphasized the
crosstalk between HSC and KC, with mutual activation among
these cells [3]. In this vein, we may wonder if the depletion of
HSC could drive KC into a less inﬂammatory phenotype.
In recent years, we have been committed to the quantitative
study of liver, establishing that HSC and KC comprise 6.4 and
8.9% of liver cells, respectively [4]. More recently, we used optical
disectors (20 lm height), that grant unbiased estimation of num-
ber [5], and concluded that 42 ± 7% of HSC were vicinal to KC
(Fig. 1). It should be stressed that such juxtaposition only stands
out in thick sections encompassing the size of both cells (even so,
some appear in Supplementary Fig. 4 of Stewart et al. [1]). Besides
paracrine stimuli, such juxtaposition should favor the crosstalk
and mutual activation between cells, contacting through fenes-
trae of sinusoidal endothelial cells. It is well established that
co-culture with KC or their conditioned medium stimulates the
activation of HSC [3,6] and some functions, e.g., selective killing
of HSC, only occur when juxtaposition with KC takes place [7].
Nowadays it is recognized that different subsets of KC coexist
in the liver [3,8,9] and a recent study showed that HSC
conditioned medium favored the differentiation of pro-inﬂammatory
macrophages [9]. Stewart et al. [1] reported that the depletion
treatment had no effect on KC, but we may hypothesize that
the loss of HSC-KC juxtaposition (and of paracrine stimuli by
HSC) could promote a switch of KC activation, lowering their
inﬂammatory response. Hypothetically, a CD68+ KC phenotype
could emerge, attracting less neutrophils and producing lessJournal of Hepatology 20
-NC-ND license.TNF-a [8]. Considering that KC predominantly express endothe-
lin-B receptors [10], this would also justify the puzzling pattern
of endothelin-A vs. B receptors. In conclusion, the KC phenotype
shift hypothesis would partially explain the data presented by
Stewart et al. [1], being alternative (or complementary) to the
view of HSC as having a critical role in acute liver conditions. This
hypothesis deserves further attention from future studies using
the HSC depletion method in acute liver injuries.
The whole liver may be viewed as an orchestra, with well-
deﬁned string, woodwind, and brass instruments (hepatocytes,
KC, and HSC in this metaphor). If in vitro studies produce simpler
tunes (one or two instruments), the methodology presented by
Stewart et al. [1] creates a much more complex and appealing
symphony. However, we are only starting to hear the melody,
and still not know if all brass instruments are alike, which are
missing and how the orchestra will hold without them.14 vol. 61 j 706–716
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Reply to: ‘‘Depletion of hepatic stellate cells: Have Kupffer
cells lost their bad neighbor?’’
To the Editor:
We appreciate the insightful commentary by Marcos on our
recently published manuscript [1], where they suggest that
the loss of communication between hepatic stellate cells (HSCs)
and closely associated Kupffer cells can be an important mecha-
nism of the amelioration of ischemia/reperfusion (I/R)- or LPS-
induced injury in HSC-depleted liver. We agree with this view
since Kupffer cells have been shown to elicit inﬂammatory
response, and their blockade or elimination ameliorates hepatic
injury in several animal models [2]. The role of Kupffer cells in
mediating HSC activation and activation-dependent ﬁbrogenic
activity through mediators including free radicals, TNF-a and
TGF-b is well documented [3]. However, little is known about
the inﬂuence of HSCs on Kupffer cells in physiology and
pathology. Thus based on the observations of our report, the
view that juxtacrine (physical contact) and paracrine (via
soluble mediators) interactions between these two cell types,
due to their close proximity, regulate physiologic and patho-
physiologic processes in the liver is a rational assessment.
The interactions between Kupffer cells and HSCs, however,
must be considered to be very complex due to heterogeneity
in the individual cell populations. Evidence suggests that the
M1 Kupffer cells play a key role in inﬂammatory diseases
whereas M2 Kupffer cells promote resolution of inﬂammation
and tissue injury [4]. Furthermore, heterogeneity in Kupffer cells
is also demonstrated with their differential phagocytic activity
and expression of biologically active mediators in periportal vs.
pericentral regions [5,6]. Similarly, heterogeneity between
periportal and pericentral HSCs has also been illustrated [7].
Nevertheless, our results [1] indicate that HSCs elicit pro-inﬂam-
matory response in Kupffer cells based on the reduced expres-
sion of TNF-a and CXCL1, and increased or unaltered
expression of IL-6 in stellate cell-depleted mice after I/R or
LPS challenge. We also observed a modest increase in anti-
inﬂammatory cytokine IL-10 expression in HSC-depleted com-
pared with control liver in both models of hepatic injury
(unpublished ﬁnding). Since HSCs themselves produce all of
these mediators [8,9], their interactions with Kupffer cells
become even more interesting and important in hepatic inﬂam-
mation and injury.
The property of HSCs to inﬂuence the characteristics of other
cell types may not be limited only to Kupffer cells. For example,
greater increase in endothelin-1 expression upon LPS challenge
of HSC-depleted liver compared to the control liver [1] indicates
their regulation of hepatic endothelial cells, the primary cell type
to produce this vasoconstrictor peptide [10]. Furthermore, HSCs
were shown to induce tolerogenicity in myeloid dendritic cells
and increase immunosuppressive potential of regulatory T cells
via physical contact, and these interactions were also found to
alter pro- and anti-inﬂammatory cytokine production by either
cell type [8,9].
We, however, note that in our study both Kupffer cells and
HSCs should be considered quiescent when the mice were sub-
jected to I/R or endotoxin challenge [1]. Although we do not
exclude the possibility that HSC depletion may already have
altered Kupffer cell characteristics, the mode of interactions
between them is expected to be quite different with their activa-
tion during progression of chronic liver injury. Thus, the hypoth-
esis that depletion of HSCs drives Kupffer cells to less
inﬂammatory phenotype (M1 to M2 switch) proposed by Marcos
and Lopez will be an interesting area for future investigation both
in acute and chronic liver injury.
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